In-vitro anticancer and antimicrobial activities of PLGA/silver nanofiber composites prepared by electrospinning
- 1.2k Downloads
- 14 Citations
Abstract
In the present work, a series of 0, 1 and 7 wt% silver nano-particles (Ag NPs) incorporated poly lactic-co-glycolic acid (PLGA) nano-fibers were synthesized by the electrospinning process. The PLGA/Ag nano-fibers sheets were characterized using SEM, TEM and DSC analyses. The three synthesized PLGA/silver nano-fiber composites were screened for anticancer activity against liver cancer cell line using MTT and LDH assays. The anticancer activity of PLGA nano-fibers showed a remarkable improvement due to increasing the concentration of the Ag NPs. In addition to the given result, PLGA nano-fibers did not show any cytotoxic effect. However, PLGA nano-fibers that contain 1 % nano silver showed anticancer activity of 8.8 %, through increasing the concentration of the nano silver to 7 % onto PLGA nano-fibers, the anticancer activity was enhanced to a 67.6 %. Furthermore, the antibacterial activities of these three nano-fibers, against the five bacteria strains namely; E.coli o157:H7 ATCC 51659, Staphylococcus aureus ATCC 13565, Bacillus cereus EMCC 1080, Listeria monocytogenes EMCC 1875 and Salmonella typhimurium ATCC25566 using the disc diffusion method, were evaluated. Sample with an enhanced inhibitory effect was PLGA/Ag NPs (7 %) which inhibited all strains (inhibition zone diameter 10 mm); PLGA/Ag NPs (1 %) sample inhibited only one strain (B. cereus) with zone diameter 8 mm. The PLGA nano-fiber sample has not shown any antimicrobial activity. Based on the anticancer as well as the antimicrobial results in this study, it can be postulated that: PLGA nanofibers containing 7 % nano silver are suitable as anticancer- and antibiotic-drug delivery systems, as they will increase the anticancer as well as the antibiotic drug potency without cytotoxicity effect on the normal cells. These findings also suggest that Ag NPs, of the size (5–10 nm) evaluated in the present study, are appropriate for therapeutic application from a safety standpoint.
Notes
Acknowledgments
The authors gratefully acknowledge funding from NPST at King Saud University Project No. (09-BIO676-02).
References
- 1.Kumar R, Münstedt H. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials. 2005;26:2081–8.CrossRefGoogle Scholar
- 2.Stobie N, Duffy B, McCormack DE, Colreavy J, Hidalgo M, McHale P, Hinder SJ. Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxysilane sol–gel coating. Biomaterials. 2008;29:963–9.CrossRefGoogle Scholar
- 3.Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents. 2009;34:103–10.CrossRefGoogle Scholar
- 4.Fortunati E, Mattioli S, Visai L, Imbriani M, Fierro JLG, Kenny JM, Armentano I. Combined effects of Ag nanoparticles and oxygen plasma treatment on PLGA morphological, chemical, and antibacterial properties. Biomacromolecules. 2013;14:626–36.CrossRefGoogle Scholar
- 5.Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. 2007;3:95–101.CrossRefGoogle Scholar
- 6.Gilchrist T, Healy DM, Drake C. Controlled silver-releasing polymers and their potential for urinary tract infection control. Biomaterials. 1991;12:76–8.CrossRefGoogle Scholar
- 7.Joyce-Wohrmann RM, Hentschel T, Munstedt HT. Thermoplastic silver-filled polyurethanes for antimicrobial catheters. Adv Eng Mater. 2000;2:380–6.CrossRefGoogle Scholar
- 8.Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, Wnek GE. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Controlled Release. 2002;81:57–64.CrossRefGoogle Scholar
- 9.Zong X, Kim K, Fang D, Ran S, Hsiao BS, Chu B. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer. 2002;43:4403–12.CrossRefGoogle Scholar
- 10.Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, Jing X. Biodegradable electrospun fibers for drug delivery. J Controlled Release. 2003;92:227–31.CrossRefGoogle Scholar
- 11.Kenawy ER, Abdel-Hay FI, El-Newehy MH, Wnek GE. Controlled release of ketoprofen from electrospun poly (vinyl alcohol) nanofibers. Mater Sci Eng A. 2007;459:390–6.CrossRefGoogle Scholar
- 12.Luong-Van E, Grøndahl L, Chua KN, Leong KW, Nurcombe V, Cool SM. Controlled release of heparin from poly (ε-caprolactone) electrospun fibers. Biomaterials. 2006;27:2042–50.CrossRefGoogle Scholar
- 13.Jiang H, Hu Y, Li Y, Zhao P, Zhu K, Chen W. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Controlled Release. 2005;108:237–43.CrossRefGoogle Scholar
- 14.Rujitanaroj PO, Pimpha N, Supaphol P. Wound-dressing materials with antibacterial activity from electrospun gelatin fiber mats containing silver nanoparticles. Polymer. 2008;49:4723–32.CrossRefGoogle Scholar
- 15.Santoveña A, Alvarez-Lorenzo C, Concheiro A, Llabrés M, Fariña JB. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release. Biomaterials. 2004;25:925–31.CrossRefGoogle Scholar
- 16.Fouad H, Elsarnagawy T, Almajhdi FN, Khalil KA. Preparation and in vitro thermo-mechanical characterization of electrospun PLGA nanofibers for soft and hard tissue replacement. Int J Electrochem Sci. 2013;8:2293–304.Google Scholar
- 17.Khalil KA, Fouad H, Elsarnagawy T, Almajhdi FN. Preparation and characterization of electrospun PLGA/silver composite nanofibers for biomedical applications. Int J Electrochem Sci. 2013;8:3483–93.Google Scholar
- 18.Hong KH, Woo SH, Kang TJ. In vitro degradation and drug-release behavior of electrospun, fibrous webs of poly (lactic-co-glycolic acid). J Appl Polym Sci. 2012;124:209–14.CrossRefGoogle Scholar
- 19.Dai W, Kawazoe N, Lin X, Dong J, Chen G. The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials. 2010;31:2141–52.CrossRefGoogle Scholar
- 20.Kim MS, Ahn HH, Shin YN, Cho MH, Khang G, Lee HB. An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds. Biomaterials. 2007;28:5137–43.CrossRefGoogle Scholar
- 21.Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(d,l-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 1996;17:1417–22.CrossRefGoogle Scholar
- 22.Abu-Saied MA, Khalil KA, Al-Deyab SS. Preparation and characterization of poly vinyl acetate nanofiber doping copper metal. Int J Electrochem Sci. 2012;7:2019–27.Google Scholar
- 23.Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119:203–10.CrossRefGoogle Scholar
- 24.Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta. 2003;1642:115–23.CrossRefGoogle Scholar
- 25.Megelski S, Stephens JS, Chase DB, Rabolt JF. Micro- and nanostructured surface morphology on electrospun polymer fibers. Macromolecules. 2002;35:8456–66.CrossRefGoogle Scholar
- 26.Fong H, Chun I, Reneker DH. Beaded nanofibers formed during electrospinning. Polymer. 1999;40:4585–92.CrossRefGoogle Scholar
- 27.Mit-uppatham C, Nithitanakul M, Supaphol P. Ultrafme electrospun polyarnide-6 fibers: effect of solution conditions on morphology and average fiber diameter. Macromol Chem Phys. 2004;205:2327–38.CrossRefGoogle Scholar
- 28.Jarusuwannapoom T, Hongrojjanawiwat W, Jitjaicham S, Wannatong L, Nithitanakul M, Pattamaprom C, Koombhongse P, Rangkupan R, Supaphol P. Effect of solvents on electro-spinnability of polystyrene solutions and morphological appearance of resulting electrospun polystyrene fibers. Eur Polymer J. 2005;41:409–21.CrossRefGoogle Scholar
- 29.Dai J, Bruening ML. Catalytic nanoparticles formed by reduction of metal ions in multilayered polyelectrolyte films. Nano Lett. 2002;2:497–501.CrossRefGoogle Scholar
- 30.Kuo PL, Chen WF. Formation of silver nanoparticles under structured amino groups in pseudo-dendritic poly(allylamine) derivatives. J Phys Chem B. 2003;107:11267–72.CrossRefGoogle Scholar
- 31.Yu H, Xu X, Chen X, Lu T, Zhang P, Jing X. Preparation and antibacterial effects of PVA-PVP hydrogels containing silver nanoparticles. J Appl Polym Sci. 2007;103:125–33.CrossRefGoogle Scholar
- 32.Travan A, Pelillo C, Donati I, Marsich E, Benincasa M, Scarpa T, Semeraro S, Turco G, Gennaro R, Paoletti S. Noncytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules. 2009;10:1429–35.CrossRefGoogle Scholar
- 33.Henglein A. Physicochemical properties of small metal particles in solution: “microelectrode” reactions, chemisorption, composite metal particles, and the atom-to-metal transition. J Phys Chem. 1993;97:5457–71.CrossRefGoogle Scholar
- 34.Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci. 2008;97:2395–404.CrossRefGoogle Scholar
- 35.Said SS, Aloufy AK, El-Halfawy OM, Boraei NA, El-Khordagui LK. Antimicrobial PLGA ultrafine fibers: Interaction with wound bacteria. Eur J Pharm Biopharm. 2011;79:108–18.CrossRefGoogle Scholar
- 36.Zheng Z, Yin W, Zara JN, Li W, Kwak J, Mamidi R, Lee M, Siu RK, Ngo R, Wang J, Carpenter D, Zhang X, Wu B, Ting K, Soo C. The use of BMP-2 coupled-nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials. 2010;35:9293–300.CrossRefGoogle Scholar
- 37.Wei X, Luo M, Li W, Yang L, Liang X, Xu L, Kong P, Liu H. Synthesis of silver nanoparticles by solar irradiation of cell-free Bacillus amyloliquefaciens extracts and AgNO3. Bioresour Technol. 2012;103:273–8.CrossRefGoogle Scholar
- 38.Liong M, France B, Bradley KA, Zink JI. Antimicrobial activity of silver nanocrystals encapsulated in mesoporous silica nanoparticles. Adv Mater. 2009;21:1684–9.CrossRefGoogle Scholar
- 39.Yoon KY, Hoon Byeon J, Park JH, Hwang J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ. 2007;373:572–5.CrossRefGoogle Scholar
- 40.Maneewattanapinyo P, Banlunara W, Thammacharoen C, Ekgasit S, Kaewamatawong T. An evaluation of acute toxicity of colloidal silver nanoparticles. J Vet Med Sci. 2011;73:1417–23.CrossRefGoogle Scholar
- 41.Liu Y, Zheng Z, Zara JN, Hsu C, Soofer DE, Lee KS, Siu RK, Miller LS, Zhang X, Carpenter D, Wang C, Ting K, Soo C. The antimicrobial and osteoinductive properties of silver nanoparticle/poly (dl-lactic-co-glycolic acid)-coated stainless steel. Biomaterials. 2012;33:8745–56.CrossRefGoogle Scholar
- 42.Stevanović MM, Škapin SD, Bračko I, Milenković M, Petković J, Filipić M, Uskoković DP. Poly(lactide-co-glycolide)/silver nanoparticles: synthesis, characterization, antimicrobial activity, cytotoxicity assessment and ROS-inducing potential. Polymer. 2012;53:2818–28.CrossRefGoogle Scholar